Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Scientists have discovered a previously unrecognized way that human airways protect lungs from infection—through the action of cilia, tiny hair-like structures lining the respiratory tract.

Anne Dockery, from Southville, Bristol, took up running at the age of 52 and began competing in triathlons in her 60s. Her ...

Bronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...

Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...

Serious conditions behind bloody cough symptoms revealed. Life-threatening diseases that cause alarming blood in cough ...

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to ...

Breathing is something we typically take for granted, until it’s a struggle to do so. When your lungs are clogged with thick, sticky mucus, each breath can be a chore. Whether it’s a seasonal cold, ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people ...

The impact of bronchiectasis on the severity of COVID-19 infection has been contradictory. Some studies report that bronchiectasis is ...